The global oral thin films market is prophesied in a report by Transparency Market Research (TMR) to find players focusing on the development of new products with a view to attain a position of strength in terms of revenue share. Strategic collaborations could be one powerful way of bringing new products to the market. There could be an increase in the level of competition observed in the market. Key players such as Aquestive Therapeutics, Inc., Indivior plc, and ZIM Laboratories Limited are looking to expand their operations across several profit-making regions of the market.
TMR expects the global oral thin films market to register a CAGR of 13.0% between 2018 and 2026. The market was worth a US$2.1 bn in 2017. Among disease indications, schizophrenia could take a lion’s share of the market during the course of the forecast period. On the geographical front, North America is foretold to show its dominance in the market while rising at a 13.0% CAGR.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42869
Need to Prevent Gastrointestinal Degradation of Acid Sensitive Drugs Increases Demand
The production of oral thin films is being upgraded to the next level with significant advancement in technology. Manufacturers are using polymeric film to offer enhanced taste masking and systematic absorption. Growing reputation of oral thin films as a novel, an emerging, and effective drug delivery system is predicted to push the growth of the market. The use of oral thin films for preventing gastrointestinal degradation of acid sensitive drugs could bode well for the market. Oral thin films can keep drugs unbroken after consumption until they dissolve.
The development of oral thin films in pharmaceutical dosage form proves their novelty in terms of drug delivery. Developed regions such as North America could witness high adoption of oral thin films in the coming years.
Request for Analysis of COVID19 Impact on Cardiac Arrest Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42869
Extortionate Cost of Oral Thin Film Treatments Paralyzes Growth of Market
Expensive cost of treatments involving oral thin films is projected to loom over the market as a threat that could discourage the rise in demand. Other factors such as the requirement of vast research investment and challenges related to drug development could hamper the demand in the global oral thin films market. However, the market is prognosticated to exhibit stable growth despite uncertainties associated with penetration rate, approval, and development.
Both startups and established names in the pharmaceutical industry have been showing great interest in oral thin films. Various advantages of oral thin films are envisaged to create a large consumer base for vendors functioning in the market. For instance, patients with swallowing difficulty are observed to prefer oral thin films. Compared to oral tablets, oral thin films have been proven quite advantageous as they improve medication safety, offer a better taste, and do not need water for consumption.
The information presented in this review is based on a TMR report, titled “Oral Thin Films Market (Product – Sublingual Film and Fast Dissolving Dental/Buccal Film; Disease Indication – Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting; Distribution Channel – Hospital Pharmacies, Drug Stores, Retail Pharmacies, and E-commerce) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026.”
Buy Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=42869<ype=S
The global oral thin films market has been segmented as presented below:
Global Oral Thin Films Market by Product
- Sublingual Film
- Fast Dissolving Dental/Buccal Film
Global Oral Thin Films Market by Disease Indication
- Schizophrenia
- Migraine
- Opioid Dependence
- Nausea and Vomiting
Browse More Reports by Transparency Market Research:
Peptide Therapeutics Market:
https://www.prnewswire.com/news-releases/high-prevalence-of-cancer-and-other-chronic-conditions-to-bode-well-for-the-peptide-therapeutics-market-however-steep-cost-of-new-therapeutic-development-could-stifle-market-growth-says-tmr-301266752.html
Implantable Cardiac Monitor Market:
https://www.prnewswire.com/news-releases/implantable-cardiac-monitor-market-to-thrive-on-increasing-incidence-of-cardiac-arrhythmias-technological-innovations-to-present-better-treatment-opportunities-for-geriatric-population-with-cardiac-conditions-tmr-301262941.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
